ADM
31
-2
SLG
74
3
REGN
65
-3
VNO
52
3
PCG
88
11
SRCL
60
3
LYB
53
2
FOXA
37
-2
IR
77
2
CA
36
4
THC
73
3
MU
36
-7
DGX
27
-2
HBI
56
11
UA
47
-4
WHR
70
-2
EQIX
48
3
QRVO
68
10
SO
66
-4
BRK.B
34
-6
ADM
31
-2
SLG
74
3
REGN
65
-3
VNO
52
3
PCG
88
11
SRCL
60
3
LYB
53
2
FOXA
37
-2
IR
77
2
CA
36
4
THC
73
3
MU
36
-7
DGX
27
-2
HBI
56
11
UA
47
-4
WHR
70
-2
EQIX
48
3
QRVO
68
10
SO
66
-4
BRK.B
34
-6
Financhill
Back

PIMCO Municipal Income Fund III Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
77

PMX
PIMCO Municipal Income Fund III

Last Price:
7.82
Seasonality Move:
0.79%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
157.33
Seasonality Move:
18.65%
Buy
77
PIMCO Municipal Income Fund III (PMX) is a Buy

Is PIMCO Municipal Income Fund III a Buy, Sell or Hold?

  • The current PIMCO Municipal Income Fund III [PMX] share price is $7.81. The Score for PMX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • PMX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $157.96. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PMX Stock Price Chart

What is PIMCO Municipal Income Fund III's stock price today?

  • The PIMCO Municipal Income Fund III share price today is $7.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PMX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $157.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 69.16 Buy
Chaikin Money Flow: 110230 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.47 - 7.67) Buy
Bollinger Bands (100): (7.41 - 7.61) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.07 Buy
Relative Strength Index (14 RSI): 68.93 Buy
Chaikin Money Flow: 909555 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.85 - 144.93) Buy
Bollinger Bands (100): (118.68 - 136.96) Buy

PMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.59 Buy
20-day SMA: 7.6 Buy
50-day SMA: 7.51 Buy
200-day SMA: 7.25 Buy
8-day EMA: 7.63 Buy
20-day EMA: 7.59 Buy
50-day EMA: 7.54 Buy
200-day EMA: 7.5 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 144.42 Buy
20-day SMA: 131.3 Buy
50-day SMA: 128.76 Buy
200-day SMA: 115.64 Buy
8-day EMA: 148.13 Buy
20-day EMA: 137 Buy
50-day EMA: 130.51 Buy
200-day EMA: 121.04 Buy

PIMCO Municipal Income Fund III Earnings Growth & PMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

PIMCO Municipal Income Fund III Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):